Production (Stage)
Fresenius Medical Care AG
FMS
$29.02
$0.48711.71%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -5.23% | 3.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.23% | 3.57% | |||
| Cost of Revenue | -4.30% | 2.33% | |||
| Gross Profit | -8.00% | 7.48% | |||
| SG&A Expenses | -11.73% | 7.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 128.75% | 41.49% | |||
| Total Operating Expenses | -5.00% | 3.89% | |||
| Operating Income | -7.76% | 0.07% | |||
| Income Before Tax | 38.15% | -54.36% | |||
| Income Tax Expenses | -1.20% | -49.25% | |||
| Earnings from Continuing Operations | 58.47% | -56.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 26.01% | 2.56% | |||
| Net Income | 123.15% | -69.55% | |||
| EBIT | -7.76% | 0.07% | |||
| EBITDA | 23.62% | -22.30% | |||
| EPS Basic | 123.21% | -69.56% | |||
| Normalized Basic EPS | -2.76% | 5.89% | |||
| EPS Diluted | 131.30% | -70.62% | |||
| Normalized Diluted EPS | -2.76% | 5.89% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||